...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Resverlogix Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office

Re: Resverlogix Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office

posted on Mar 15, 2017 09:16AM

FYI, here's a link to the patent entitled "COMPOSITIONS AND THERAPEUTIC METHODS FOR ACCELERATED PLAQUE REGRESSION". Here's a 2013 news release on the potential RVX-208/rosuvastatin synergy for those that aren't aware already.

BDAZ

P.S. Led, your comment about Duke made me throw up a little

 

Share
New Message
Please login to post a reply